L-R: Hiromi Furushima, Takahiro Yanagimoto, Shigehiro Kawase
19 June 2025NewsCareersMarisa Woutersen

Japanese firm adds ex-Norvartis and Alnylam in-house counsel

Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
3 August 2026   Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes.
Careers
31 July 2026   The ex-Greenberg Traurig shareholder will oversee the office’s 14,000-strong patent division, as the agency prepares for the departure of deputy director Coke Morgan Stewart.
Careers
29 July 2026   The engineer-turned-lawyer joins as a principal, bringing 15 years of experience advising on patent strategy across AI, software, and medical devices.